Weight loss drugs firm expands into heart disease treatment
The Nova Nordisk deal is due to be wrapped up in the second quarter of this year. It will help establish the maker of Wegovy and Ozempic in the cardiovascular treatment market. Pharmaceutical giant Novo Nordisk is to take over German biotech company Cardior Pharmaceuticals in a deal worth up to…#novanordisk #wegovyandozempic #novonordisk #novo #cardior #rna #martinholstlange #cdr132l #claudiaulbrich #elililly
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Biotechnology | Cardiology | Cardiovascular | Germany Health | Health | Heart | Heart Disease | Profits and Losses | Weight Loss